Crispr Therapeutics shares owned by Bellevue Group
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Bellevue Group
from 13F filings
Historical chart of Bellevue Group investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Bellevue Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Bellevue Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $29M | 610k | 46.98 |
| 2024-06-30 | $33M | 618k | 54.01 |
| 2024-03-31 | $42M | 620k | 68.16 |
| 2023-12-31 | $56M | 900k | 62.60 |
| 2023-09-30 | $41M | 898k | 45.39 |
| 2023-06-30 | $51M | 899k | 56.14 |
| 2023-03-31 | $41M | 900k | 45.23 |
| 2022-12-31 | $37M | 912k | 40.65 |
| 2022-09-30 | $61M | 928k | 65.35 |
| 2022-06-30 | $56M | 922k | 60.78 |
| 2022-03-31 | $58M | 927k | 62.78 |
| 2021-12-31 | $74M | 975k | 75.78 |
| 2021-09-30 | $109M | 975k | 111.91 |
| 2021-06-30 | $157M | 967k | 161.91 |
| 2021-03-31 | $119M | 978k | 121.82 |
| 2020-12-31 | $139M | 910k | 153.07 |
| 2020-09-30 | $79M | 949k | 83.64 |
| 2020-06-30 | $59M | 801k | 73.49 |
| 2020-03-31 | $34M | 801k | 42.41 |
| 2019-12-31 | $45M | 731k | 60.91 |
| 2019-09-30 | $34M | 837k | 40.97 |
| 2019-06-30 | $38M | 811k | 47.10 |